These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 20218123)
1. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis. Tabarsi P; Baghaei P; Hemmati N; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR East Mediterr Health J; 2009; 15(6):1346-50. PubMed ID: 20218123 [TBL] [Abstract][Full Text] [Related]
2. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM; Goldberg SV Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [TBL] [Abstract][Full Text] [Related]
3. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
4. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report. Ige OM; Bakare NA; Onadeko BO Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
6. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related]
7. [Combined chemotherapy of patients with tuberculosis - new regimens and dosage forms]. Sokolova GB; Koriakin VA; Khalbaeva IV; Elistratova NA; Ziia AV Probl Tuberk; 1993; (5):21-3. PubMed ID: 8295879 [TBL] [Abstract][Full Text] [Related]
8. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC; Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516 [TBL] [Abstract][Full Text] [Related]
9. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment]. Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263 [TBL] [Abstract][Full Text] [Related]
10. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
11. [Standardized controlled antitubercular therapy and results in 755 patients]. Wiesner B; Cramer G; Hamel U; Roth G Z Erkr Atmungsorgane; 1991; 177(1-2):71-5. PubMed ID: 1808855 [TBL] [Abstract][Full Text] [Related]
12. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru. Morales S; Ramos W; Vílchez R; Pérez J; Alvarado M Neurologia; 2011 May; 26(4):220-6. PubMed ID: 21163196 [TBL] [Abstract][Full Text] [Related]
14. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [TBL] [Abstract][Full Text] [Related]
15. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Shah AR; Agarwal SK; Shah KV Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118 [TBL] [Abstract][Full Text] [Related]
16. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society. Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028 [TBL] [Abstract][Full Text] [Related]
17. 4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong. Chan SL; Wong PC; Tam CM Tuber Lung Dis; 1994 Aug; 75(4):245-50. PubMed ID: 7949069 [TBL] [Abstract][Full Text] [Related]
18. Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Datta M; Radhamani MP; Selvaraj R; Paramasivan CN; Gopalan BN; Sudeendra CR; Prabhakar R Tuber Lung Dis; 1993 Jun; 74(3):180-6. PubMed ID: 8369512 [TBL] [Abstract][Full Text] [Related]
19. Outpatient management of tuberculosis. McColloster P; Neff NE Am Fam Physician; 1996 Apr; 53(5):1579-94. PubMed ID: 8623687 [TBL] [Abstract][Full Text] [Related]
20. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]